H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Census population 383,997. Louisiana Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New Orleans clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New Orleans storefront.
For Wound Care Specialists in New Orleans, LA for clinics & physicians. Advanced wound care products for w… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Census city-proper population is 383,997. If you are adding wound care specialists, start with that epidemiology and with Novitas Solutions (JH) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National For Wound Care Specialists notes (how the product actually works)CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Adult obesity in New Orleans is 34% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 25.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, MS, NM, OK, TX. Louisiana Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy wound care specialists elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 15.1% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 15.1% of adults — 3.1 points above the U.S. 12% figure. Obesity is 34%; arthritis is 25.3%. That is place-level BRFSS modeling, not a clinic census and not a New Orleans trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Louisiana compliance risk.
Use the contact form or book a 15-minute call with Joe Bradley. Bring specialty, monthly wound or joint volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
Ask for the IFU, the lot-traceability packet, and the Novitas Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a New Orleans fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in New Orleans, LA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New Orleans is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New Orleans — 3.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Louisiana Part B wound biologics follow this contractor (siblings: AR, CO, MS, NM, OK, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New Orleans. Useful for joint-program math; still needs a diagnosis and privileging.
No New Orleans storefront. Joe Bradley is an active practice owner. wound care specialists stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.